Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019-Reference-Cited by-同舟云学术

Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019

Published:2020-10 Issue:4 Volume:158 Page:1397-1408
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Price Christina C.,Altice Frederick L.,Shyr Yu,Koff Alan,Pischel Lauren,Goshua George,Azar Marwan M.,Mcmanus Dayna,Chen Sheau-Chiann,Gleeson Shana E.,Britto Clemente J.,Azmy Veronica,Kaman Kelsey,Gaston David C.,Davis Matthew,Burrello Trisha,Harris Zachary,Villanueva Merceditas S.,Aoun-Barakat Lydia,Kang Insoo,Seropian Stuart,Chupp Geoffrey,Bucala Richard,Kaminski Naftali,Lee Alfred I.,LoRusso Patricia Mucci,Topal Jeffrey E.,Dela Cruz Charles,Malinis Maricar

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference27 articles.

1. pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review;Sanders;JAMA,2020

2. C reactive protein level may predict the risk of COVID-19 aggravation;Wang;Open Forum Infect Dis,2020

3. Cytokine release syndrome in severe COVID-19;Moore;Science,2020

4. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China;Wu;JAMA Intern Med,2020

5. The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis;Yang;J Infect,2020

Cited by 175 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Postacute Sequelae of COVID (PASC or Long COVID): An Evidenced-Based Approach;Open Forum Infectious Diseases;2024-08-27

2. IP-10, MIP1α, IL-6, and IL-1β as Biomarkers Associated with Disease Severity of COVID-19;Jundishapur Journal of Microbiology;2024-06-09

3. Even one dose of tocilizumab could hinder bad prognosis of cytokines storm in COVID-19 patients;Cytokine;2024-01

4. Interleukin-6 in Traumatic Brain Injury: A Janus-Faced Player in Damage and Repair;Journal of Neurotrauma;2023-11-01

5. Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study;Life;2023-08-16